NCT04760951View on ClinicalTrials.gov

Effect of Totum-070 on Lipid Metabolism in Moderate Hypercholesterolemic Subjects

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

February 17, 2021

Primary Completion Date

February 17, 2022

Study Completion Date

February 17, 2022

Conditions
HypercholesterolemiaCardiovascular Risk FactorDyslipidemiasOverweight and ObesityAtherosclerosis
Interventions
DIETARY_SUPPLEMENT

TOTUM-070

5-g dose of TOTUM-070 diet supplement, a mix of 5 plant extracts. Eight capsules per day to consume orally in two intakes

DIETARY_SUPPLEMENT

Placebo

Placebo. Eight capsules per day to consume orally in two intakes

Trial Locations (4)

44800

Biofortis Mérieux NutriSciences, Saint-Herblain

59019

Institut Pasteur de Lille, Lille

73728

Biotesys, Esslingen am Neckar

75012

Unité d'Investigation Clinique Biofortis Mérieux NutriSciences, Paris

All Listed Sponsors
collaborator

Biofortis Mérieux NutriSciences

OTHER

lead

Valbiotis

INDUSTRY

NCT04760951 - Effect of Totum-070 on Lipid Metabolism in Moderate Hypercholesterolemic Subjects | Biotech Hunter | Biotech Hunter